Pfizer's Dolsten On Finding Ways To “Accelerate External Science”
Part 2 Of 2
Executive Summary
Worldwide President of R&D Mikael Dolsten talked to Scrip about Pfizer's busy business development track record and the company's ambition to maintain its leadership in breast cancer.